InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the full record of transactions filed by Fu Wei, 管理人员. Director active across 1 company, notably Everest Medicines Ltd.. In total, 9 reports have been logged. Activity tracked since 27 March 2026. The latest transaction was disclosed on 17 June 2026 (Purchase). Regulator: HKEX. All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
FU WEI is an executive at Everest Medicines Ltd. He oversees the company's operations, which specializes in developing innovative medicines. His expertise is crucial for the company's research and development strategy.